Throat Carcinoma — Trials

Throat Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,035 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 369
Recruiting: 201
Ph III recruiting: 58
Growth YoY: +7.8%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 31.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (87)

clinicaltrialsPublishedShowing 1–50 of 110 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03258554	Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin	completed	Phase 2 / Phase 3	196	National Cancer Institute (NCI)NIH	2	Aug 27, 2026	clinicaltrials
NCT04943445	Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers(SMART-KEY)	completed	Phase 2	43	Latin American Cooperative Oncology GroupOTHER	1